GeneDx Holdings Corp. (WGS)
151.51
-3.86
(-2.48%)
USD |
NASDAQ |
Dec 12, 16:00
152.00
+0.49
(+0.32%)
After-Hours: 20:00
GeneDx Holdings Research and Development Expense (Quarterly): 19.59M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 228.00M |
| Labcorp Holdings, Inc. | -- |
| Delcath Systems, Inc. | 7.986M |
| Star Operating Cos., Inc. | -- |
| CytoSorbents Corp. | 0.918M |